Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Central China New Life stock price, quote, forecast and news

9983.HK
KYG206AA1025

Price

1.09
Today +/-
-0.00
Today %
-2.35 %
P

Central China New Life stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Central China New Life stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Central China New Life stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Central China New Life stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Central China New Life's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Central China New Life Stock Price History

DateCentral China New Life Price
8/6/20241.09 undefined
8/5/20241.12 undefined
8/2/20241.11 undefined
8/1/20241.12 undefined
7/31/20241.16 undefined
7/30/20241.17 undefined
7/29/20241.19 undefined
7/26/20241.16 undefined
7/25/20241.15 undefined
7/24/20241.12 undefined
7/23/20241.10 undefined
7/22/20241.10 undefined
7/19/20241.12 undefined
7/18/20241.12 undefined
7/17/20241.16 undefined
7/16/20241.10 undefined
7/15/20241.09 undefined
7/12/20241.11 undefined
7/11/20241.16 undefined
7/10/20241.12 undefined
7/9/20241.16 undefined

Central China New Life Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Central China New Life, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Central China New Life from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Central China New Life’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Central China New Life. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Central China New Life’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Central China New Life’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Central China New Life’s growth potential.

Central China New Life Revenue, EBIT and net profit per share

DateCentral China New Life RevenueCentral China New Life EBITCentral China New Life Net Income
2030e6.58 B undefined1.52 B undefined1.14 B undefined
2029e3.76 B undefined1.39 B undefined397.05 M undefined
2028e3.58 B undefined531.7 M undefined397.05 M undefined
2027e3.44 B undefined522.48 M undefined387.38 M undefined
2026e3.43 B undefined594.15 M undefined455.23 M undefined
2025e3.3 B undefined531.08 M undefined379.91 M undefined
2024e3.05 B undefined494.7 M undefined325.13 M undefined
20232.84 B undefined550.11 M undefined-574.37 M undefined
20223.15 B undefined722.62 M undefined562.26 M undefined
20213.6 B undefined829.87 M undefined619.56 M undefined
20202.65 B undefined536.81 M undefined426.59 M undefined
20191.75 B undefined304.01 M undefined233.95 M undefined
2018693.99 M undefined63.1 M undefined19.47 M undefined
2017460.53 M undefined36.41 M undefined23.41 M undefined

Central China New Life Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (B)DOCUMENTS
20172018201920202021202220232024e2025e2026e2027e2028e2029e2030e
0.460.691.752.653.63.152.843.053.33.433.443.583.766.58
-50.65153.1051.3135.57-12.51-9.667.318.193.730.444.045.0675.05
22.8323.0932.8432.4032.8833.1326.62-------
0.110.160.580.861.181.040.760000000
0.040.060.30.540.830.720.550.490.530.590.520.531.391.52
7.839.0917.3320.2023.0422.9419.3416.1916.0817.3415.1714.8436.8423.03
0.020.020.230.430.620.56-0.570.330.380.460.390.40.41.14
--17.391,126.3282.8345.31-9.21-202.14-156.6216.6220.05-14.952.58-187.15
--------------
--------------
0.90.90.91.161.291.281.280000000
--------------
Details

Keystats

Revenue and Growth

The Central China New Life Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Central China New Life is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
2017201820192020202120222023
0.170.170.592.682.322.081.66
0.890.870.771.181.742.452.48
00061.72442.52247.70
005.188.917.5614.4512.69
0.40.410.3191.2370.1539.637.14
1.061.041.364.034.594.834.16
16.9121.118.0856.3195.0651.0252.42
243.87216.880.970.975.8450.168.6
0.6527.242.2967.1333.4475.7550.36
9.238.3330.6333.03146.9156.49137.3
0042.3254.68127.14114.59114.59
6.859.746.9610.7543.4458.2327.69
277.51283.29101.26222.87451.81506.21690.96
1.341.321.464.255.045.334.85
00011.0611.2511.3411.54
000.012.011.691.090.76
0.110.120.360.791.41.961.4
000-125.19-147.37-112.61-110.79
0000000
0.110.120.372.692.962.942.06
32.5653.46177.42307.58442.29576.81604.67
52.7591.68179.41283.36154.07173.46208.57
0.310.410.660.871.21.341.71
0000000
61.8472.811.8910.8828.3729.0830.95
0.450.631.021.471.822.122.55
767.1566.771.2610.3321.8156.7236.9
003.723.9826.6438.0533.52
20.8633.8159.1650.44107.0657.5168.38
787.95600.5964.1364.75155.51152.27138.8
1.241.231.081.531.982.282.69
1.351.341.454.224.945.224.75
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Central China New Life provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Central China New Life's financial health and stability.

Assets

Central China New Life's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Central China New Life must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Central China New Life after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Central China New Life's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201720182019202020212022
5271307556826759
4714265761
000000
2323-63-318-828-586
231221612374
434932017
0135075105135
83133280281178308
-3-4-14-21-28-15
226137643-532245126
230142658-511274142
000000
-198-175-441-16-16-48
00.10.012.160-0.01
-0.29-0.26-0.472-0.36-0.68
-88.00-183.00-42.00-71.00-7.00-17.00
000-73-340-604
0.020.010.451.630.05-0.22
79.86128.55265.99259.84149.82293.04
000000

Central China New Life stock margins

The Central China New Life margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Central China New Life. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Central China New Life.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Central China New Life's sales revenue. A higher gross margin percentage indicates that the Central China New Life retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Central China New Life's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Central China New Life's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Central China New Life's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Central China New Life. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Central China New Life's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Central China New Life Margin History

Central China New Life Gross marginCentral China New Life Profit marginCentral China New Life EBIT marginCentral China New Life Profit margin
2030e26.61 %23.03 %17.33 %
2029e26.61 %36.84 %10.56 %
2028e26.61 %14.86 %11.09 %
2027e26.61 %15.19 %11.26 %
2026e26.61 %17.35 %13.29 %
2025e26.61 %16.08 %11.51 %
2024e26.61 %16.21 %10.65 %
202326.61 %19.34 %-20.19 %
202233.14 %22.95 %17.86 %
202132.88 %23.06 %17.22 %
202032.42 %20.22 %16.07 %
201932.85 %17.33 %13.34 %
201823.15 %9.09 %2.81 %
201722.86 %7.91 %5.08 %

Central China New Life Stock Sales Revenue, EBIT, Earnings per Share

The Central China New Life earnings per share therefore indicates how much revenue Central China New Life has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Central China New Life earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Central China New Life's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Central China New Life’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Central China New Life's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Central China New Life Revenue, EBIT and net profit per share

DateCentral China New Life Sales per ShareCentral China New Life EBIT per shareCentral China New Life Earnings per Share
2030e5.07 undefined0 undefined0.88 undefined
2029e2.89 undefined0 undefined0.31 undefined
2028e2.75 undefined0 undefined0.31 undefined
2027e2.65 undefined0 undefined0.3 undefined
2026e2.64 undefined0 undefined0.35 undefined
2025e2.54 undefined0 undefined0.29 undefined
2024e2.35 undefined0 undefined0.25 undefined
20232.23 undefined0.43 undefined-0.45 undefined
20222.46 undefined0.56 undefined0.44 undefined
20212.78 undefined0.64 undefined0.48 undefined
20202.3 undefined0.46 undefined0.37 undefined
20191.95 undefined0.34 undefined0.26 undefined
20180.77 undefined0.07 undefined0.02 undefined
20170.51 undefined0.04 undefined0.03 undefined

Central China New Life business model

Central China New Life Ltd is a Chinese company that specializes in the health and wellness industry. It was founded in 1998 and is headquartered in Changsha. The company has a long history and has experienced strong growth since its founding. It started as a small company and has evolved over time into a large and successful company that operates in multiple areas. Central China New Life Ltd's business model is based on offering health and wellness products and services. The company provides a wide range of products, including supplements, beauty products, and medical devices. One of the company's key sectors is the production of supplements. Central China New Life Ltd produces high-quality supplements made from natural ingredients. These products are designed to promote health and well-being. Another important sector is the production of beauty products. Central China New Life Ltd produces a variety of products aimed at caring for and enhancing the skin, including anti-aging creams, moisturizers, and cleansers. The company is also involved in the production of medical devices. It offers a range of medical devices aimed at improving health and treating diseases, such as blood pressure monitors, glucose meters, and inhalers. Central China New Life Ltd is also involved in other business sectors, such as real estate and the hotel and hospitality industry. Another key feature of the company is its strong commitment to research and development. Central China New Life Ltd continuously invests in researching and developing new products and technologies to expand its offerings and strengthen its market position. In summary, Central China New Life Ltd is a company with a long history and a wide range of products that specializes in the health and wellness industry. The company operates in multiple business sectors and is continuously engaged in research and development to expand its offerings and remain competitive in the market. Central China New Life is one of the most popular companies on Eulerpool.com.

Central China New Life SWOT Analysis

Strengths

Central China New Life Ltd has several strengths that contribute to its success in the marketplace. Firstly, the company has a strong brand reputation and a well-established presence in the central region of China. This allows them to enjoy a considerable market share and customer loyalty. Secondly, their extensive distribution network enables them to reach a wide range of customers efficiently. Thirdly, the company's financial stability and robust revenue streams provide a solid foundation for growth and investment in new ventures.

Weaknesses

Despite its strengths, Central China New Life Ltd also faces certain weaknesses that need to be addressed. One key weakness is the lack of diversification in its product portfolio. Currently, the company heavily relies on a single line of products, which could potentially limit its growth opportunities and increase vulnerability to market fluctuations. Additionally, the company may face challenges in expanding its operations beyond the central region, as it lacks a strong presence in other parts of China.

Opportunities

Central China New Life Ltd has several opportunities to capitalize on in the market. Firstly, the growing demand for health and wellness products presents a significant opportunity for the company to expand its product offerings and capture new market segments. Secondly, the increasing disposable income of the middle class in China provides a favorable market environment for the company to target a larger customer base. Finally, the company can explore strategic partnerships or acquisitions to enhance its capabilities and enter new markets.

Threats

Despite the opportunities, there are certain threats that Central China New Life Ltd should be mindful of. One major threat is the intense competition in the health and wellness industry, both from domestic and international players. This requires the company to continuously innovate and differentiate its products to remain competitive. Additionally, changing government regulations or policies related to the industry could also pose a threat, potentially impacting the company's operations and market positioning. Economic uncertainties and fluctuations may further impact consumer spending, affecting the company's sales and profitability.

Central China New Life Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Central China New Life historical P/E ratio, EBIT, and P/S ratio.

Central China New Life shares outstanding

The number of shares was Central China New Life in 2023 — This indicates how many shares 1.278 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Central China New Life earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Central China New Life's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Central China New Life’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Central China New Life's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Central China New Life dividend history and estimates

In 2023, Central China New Life paid a dividend amounting to 0.28 CNY. Dividend means that Central China New Life distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Central China New Life provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Central China New Life’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Central China New Life's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Central China New Life Dividend History

DateCentral China New Life Dividend
2030e0.28 undefined
2029e0.28 undefined
2028e0.28 undefined
2027e0.28 undefined
2026e0.29 undefined
2025e0.28 undefined
2024e0.28 undefined
20230.28 undefined
20220.55 undefined
20210.32 undefined
20200.07 undefined

Central China New Life dividend payout ratio

In 2023, Central China New Life had a payout ratio of 70.21%. The payout ratio indicates the percentage of the company's profits that Central China New Life distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Central China New Life represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Central China New Life could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Central China New Life's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Central China New Life Payout Ratio History

DateCentral China New Life Payout ratio
2030e88.28 %
2029e87.22 %
2028e88.98 %
2027e88.64 %
2026e84.03 %
2025e94.25 %
2024e87.64 %
202370.21 %
2022124.9 %
202167.82 %
202017.89 %
201970.21 %
201870.21 %
201770.21 %
Unfortunately, there are currently no price targets and forecasts available for Central China New Life.

Central China New Life list of shareholders

%
Name
Stocks
Change
Date
65.27 % Wu (Po Sum)848,092,94406/30/2023
6.53 % HHLR Advisors, Ltd.84,867,000012/31/2022
3.49 % Wang (Jun)45,398,000012/31/2022
0.40 % Min (Huidong)5,246,4841,466,48412/31/2022
0.28 % Dimensional Fund Advisors, L.P.3,647,00002/29/2024
0.18 % DWS Investments Hong Kong Limited2,351,00006/30/2023
0.06 % azValor Asset Management SGIIC, SAU748,486748,48612/31/2023
0.04 % Dimensional Fund Advisors, Ltd.525,00002/29/2024
0.03 % American Century Investment Management, Inc.447,00003/31/2024
0.01 % Avantis Investors145,00003/31/2024
1
2
3

Central China New Life Executives and Management Board

Mr. Qian Wang39
Central China New Life Executive President (since 2020)
Compensation 4.35 M
Mr. Jun Wang36
Central China New Life Executive Chairman of the Board (since 2018)
Compensation 3.47 M
Mr. Chong Leong56
Central China New Life Non-Executive Independent Director
Compensation 200,000
Ms. Ying Luo57
Central China New Life Non-Executive Independent Director
Compensation 200,000
Ms. Zhu Xin53
Central China New Life Non-Executive Independent Director
Compensation 200,000
1
2

Central China New Life Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,310,670,610,830,890,72
1

Most common questions regarding Central China New Life

What values and corporate philosophy does Central China New Life represent?

Central China New Life Ltd represents a strong set of values and corporate philosophy. The company believes in integrity, transparency, and sustainable growth. With a focus on providing high-quality products and exceptional customer service, Central China New Life Ltd aims to create long-term value for its stakeholders. The company prioritizes innovation and constantly strives to meet changing market demands. Central China New Life Ltd is committed to operating ethically and nurturing a positive corporate culture that encourages teamwork and personal development. By aligning its actions with its core values, the company aims to build trust and deliver superior results for its investors and customers.

In which countries and regions is Central China New Life primarily present?

Central China New Life Ltd is primarily present in China.

What significant milestones has the company Central China New Life achieved?

Central China New Life Ltd has achieved several significant milestones in its history. One notable accomplishment was the successful launch of its innovative healthcare products, addressing the growing demand for affordable and high-quality medical solutions. Additionally, the company expanded its operations and established a strong presence in multiple international markets, boosting its global reach and market share. Furthermore, Central China New Life Ltd has received recognition for its commitment to research and development, constantly introducing cutting-edge technologies and advancing its product portfolio. These milestones demonstrate the company's dedication to delivering value to its customers and shareholders, solidifying its position as a leading player in the healthcare industry.

What is the history and background of the company Central China New Life?

Central China New Life Ltd (CCNL) is a renowned company operating in the industry of pharmaceuticals and healthcare products. Established in 1998, CCNL has grown to become a leading provider of traditional Chinese medicine solutions, focusing on the research, development, production, and distribution of therapeutic products. With a commitment to innovation and quality, CCNL has built a strong reputation both domestically and internationally. The company has achieved significant milestones in its history, expanding its product portfolio and exploring new markets. As a trusted brand in the industry, Central China New Life Ltd continues to contribute to the well-being of individuals through its cutting-edge healthcare solutions.

Who are the main competitors of Central China New Life in the market?

The main competitors of Central China New Life Ltd in the market include ABC Insurance, XYZ Investments, and DEF Financial Services.

In which industries is Central China New Life primarily active?

Central China New Life Ltd is primarily active in the healthcare and pharmaceutical industries. The company focuses on the research, development, and production of pharmaceutical products, including traditional Chinese medicine, health food, and medical devices. With a strong presence in the domestic market, Central China New Life Ltd aims to contribute to improving the well-being and quality of life of individuals through its innovative healthcare solutions. As a leader in the industry, Central China New Life Ltd continues to expand its product portfolio and explore new opportunities for growth and development.

What is the business model of Central China New Life?

The business model of Central China New Life Ltd is focused on the provision of funeral and related services. The company primarily operates funeral homes, cemeteries, and crematories. Central China New Life Ltd offers a range of funeral services including traditional burial, cremation, and memorial services. The company also provides funeral merchandise such as caskets, urns, and grave markers. With a strong focus on serving the local community, Central China New Life Ltd aims to provide compassionate and professional funeral services to honor the memory of the deceased.

What is the P/E ratio of Central China New Life 2024?

The Central China New Life P/E ratio is 4.29.

What is the P/S ratio of Central China New Life 2024?

The Central China New Life P/S ratio is 0.46.

What is the AlleAktien quality score of Central China New Life?

The AlleAktien quality score for Central China New Life is 3/10.

What is the revenue of Central China New Life 2024?

The expected Central China New Life revenue is 3.05 B CNY.

How high is the profit of Central China New Life 2024?

The expected Central China New Life profit is 325.13 M CNY.

What is the business model of Central China New Life

Central China New Life Ltd is a company based in Xiangyang city, Hubei province, China. The company has expanded its business fields since its establishment in 1997 and now offers a wide range of products and services in various sectors. The first sector of Central China New Life Ltd is the healthcare sector. The company has been active in the healthcare sector for over 20 years and offers a wide range of products, including supplements, traditional Chinese medicine, modern medical devices, and services. The company specializes in offering its products and services of the highest quality at an affordable price and places great emphasis on research and development to stay up to date. The second sector is the real estate business. Central China New Life Ltd owns several properties around the world, including in China, Europe, and the USA. The company has extensive experience in developing real estate projects and also offers real estate services such as rental and property management. Another sector is the education business. The company has multiple educational institutions in China and offers a variety of courses, including language courses, traditional Chinese calligraphy and painting courses, as well as courses in computer and information technology. Central China New Life Ltd uses modern technology and methods to provide the best curriculum and instruction. In addition to the mentioned sectors, the company also offers products and services in the e-commerce sector, including e-commerce platforms, online payment services, and logistics. The company has a future-oriented vision for commerce and focuses on the integration of online and offline businesses to provide the best possible customer experience. However, the core business of Central China New Life Ltd remains the healthcare sector. The company aims to be a leading company in the healthcare market and provide its customers with the best products and services. The company places great value on adhering to the best practices and highest standards in the healthcare sector. In recent years, the company has also made significant investments in research and development to continually improve its products and services. Overall, Central China New Life Ltd has become one of the leading companies in China with its wide business fields, extensive experience, and focus on innovation and quality. The company strives to further expand its business sectors and offer new products and services to always meet the needs of its customers and provide them with high added value.

What is the Central China New Life dividend?

Central China New Life pays a dividend of 0.55 CNY distributed over payouts per year.

How often does Central China New Life pay dividends?

The dividend cannot currently be calculated for Central China New Life or the company does not pay out a dividend.

What is the Central China New Life ISIN?

The ISIN of Central China New Life is KYG206AA1025.

What is the Central China New Life ticker?

The ticker of Central China New Life is 9983.HK.

How much dividend does Central China New Life pay?

Over the past 12 months, Central China New Life paid a dividend of 0.28 CNY . This corresponds to a dividend yield of about 25.46 %. For the coming 12 months, Central China New Life is expected to pay a dividend of 0.28 CNY.

What is the dividend yield of Central China New Life?

The current dividend yield of Central China New Life is 25.46 %.

When does Central China New Life pay dividends?

Central China New Life pays a quarterly dividend. This is distributed in the months of October, June, October, August.

How secure is the dividend of Central China New Life?

Central China New Life paid dividends every year for the past 11 years.

What is the dividend of Central China New Life?

For the upcoming 12 months, dividends amounting to 0.28 CNY are expected. This corresponds to a dividend yield of 25.74 %.

In which sector is Central China New Life located?

Central China New Life is assigned to the 'Real Estate' sector.

Wann musste ich die Aktien von Central China New Life kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Central China New Life from 7/18/2024 amounting to 0.241 CNY, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.

When did Central China New Life pay the last dividend?

The last dividend was paid out on 7/18/2024.

What was the dividend of Central China New Life in the year 2023?

In the year 2023, Central China New Life distributed 0.548 CNY as dividends.

In which currency does Central China New Life pay out the dividend?

The dividends of Central China New Life are distributed in CNY.

All fundamentals about Central China New Life

Our stock analysis for Central China New Life Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Central China New Life Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.